Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
Authors
Keywords
Vasodilation, Middle meningeal artery, Migraine, CGRP
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-04-23
DOI
10.1186/1129-2377-15-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
- (2013) Faisal Mohammad Amin et al. LANCET NEUROLOGY
- VIP/PACAP receptors in cerebral arteries of rat: Characterization, localization and relation to intracellular calcium
- (2013) André Erdling et al. NEUROPEPTIDES
- Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method
- (2012) Gustaf Grände et al. CEPHALALGIA
- Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura
- (2012) Maria Antonova et al. CEPHALALGIA
- CGRP and NO in the Trigeminal System: Mechanisms and Role in Headache Generation
- (2012) Karl Messlinger et al. HEADACHE
- Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Potently Dilates Middle Meningeal Arteries: Implications for Migraine
- (2012) Arsalan U. Syed et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Tracing neural connections to pain pathways with relevance to primary headaches
- (2011) Lars Edvinsson CEPHALALGIA
- Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
- (2011) Faisal Mohammad Amin et al. CEPHALALGIA
- Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat
- (2011) Michael Baun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries
- (2011) Christina Kruuse et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evidence for a vascular factor in migraine
- (2010) Mohammad S. Asghar et al. ANNALS OF NEUROLOGY
- Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
- (2010) Kayi Y Chan et al. CEPHALALGIA
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Migraine Pain and Nociceptor Activation-Where Do We Stand?
- (2010) Dan Levy HEADACHE
- New drugs in migraine treatment and prophylaxis: telcagepant and topiramate
- (2010) Lars Edvinsson et al. LANCET
- Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers
- (2010) M. S. Asghar et al. NEUROLOGY
- Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura
- (2009) HW Schytz et al. CEPHALALGIA
- The in vivo Effect of VIP, PACAP-38 and PACAP-27 and mRNA Expression of Their Receptors in Rat Middle Meningeal Artery
- (2009) LJ Boni et al. CEPHALALGIA
- Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs
- (2009) T Wienecke et al. CEPHALALGIA
- Middle Meningeal Artery Dilatation in Migraine
- (2009) Elliot Shevel HEADACHE
- Origin of pain in migraine: evidence for peripheral sensitisation
- (2009) Jes Olesen et al. LANCET NEUROLOGY
- PACAP38 induces migraine-like attacks in patients with migraine without aura
- (2008) Henrik Winther Schytz et al. BRAIN
- The Blood-Brain Barrier in Migraine Treatment
- (2008) L Edvinsson et al. CEPHALALGIA
- Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine
- (2008) A Rahmann et al. CEPHALALGIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started